TOP20 Gynecological Chinese patent medicine retailer released 10 exclusive products "Baping"

This year's government work report proposes to support the revitalization and development of traditional Chinese medicine and promote the comprehensive reform of traditional Chinese medicine
.
Under the background of national top-level policy support and internationalization, the traditional Chinese medicine industry has huge room for growth, and various sub-sectors will usher in a golden period of development
.
According to data from Minet.
com, it is estimated that in 2021, the market size of Chinese patent medicine for gynecology in China's urban physical pharmacies will exceed 5 billion yuan
.
From the perspective of the top 20 manufacturers, Zhuzhou Qianjin Pharmaceutical, Shanxi Guangyu Yuanguo Pharmaceutical, Jiuzhitang, Zhongjing Wanxi Pharmaceutical, and Sichuan Enwei Pharmaceutical ranked in the top five
.
10 of the TOP20 products are exclusive, and 5 are up more than 10%
.
Among the top 20 brands, Dingkundan from Shanxi Guangyu Yuanguo Pharmaceutical, Jieeryin Lotion from Sichuan Enwei Pharmaceutical, and Xiaoyao Pill from Zhongjing Wanxi Pharmaceutical ranked the top three; in terms of quantity, Zhuzhou Qianjin Pharmaceutical Co.
4
.
5 billion market! Gynecological menstruation drugs and gynecological inflammation drugs together account for more than 80% of the sub-category pattern of gynecological Chinese patent medicine in Chinese urban physical pharmacies in 2021E Source: MINET Sales exceeded 5 billion yuan
.
From the perspective of sub-category, gynecological menstruation drugs and gynecological inflammation drugs are still the two main players, with a combined market share of more than 80%
.
And gynecological abortion pills have the fastest growth rate, with a year-on-year increase of nearly 40%
.
From the perspective of the TOP20 manufacturers, Zhuzhou Qianjin Pharmaceutical, Shanxi Guangyu Yuanguo Pharmaceutical, Jiuzhitang, Zhongjing Wanxi Pharmaceutical, and Sichuan Enwei Pharmaceutical are among the top five; Baiyunshan Zhongyi Pharmaceutical and Kunming Traditional Chinese Medicine have the fastest growth rates, both exceeding 40%
.
TOP20 is out! 10 exclusive products "Baping", these 5 products have increased by more than 10% 2021E TOP20 Chinese patent medicine products in gynecology in Chinese urban physical pharmacies Source: Minet.
com China's urban physical pharmacy terminal competition Note: *In the exclusive TOP20 products, there are 10 exclusive products The products involved 7 companies including Zhuzhou Qianjin Pharmaceutical, Shandong Buchang Shenzhou Pharmaceutical, and Sichuan Enwei Pharmaceutical.
Among them, 5 exclusive products such as Jieeryin Lotion, Baofukang Suppository and Gynecology Qianjin Tablet are among the top ten.

.
In terms of growth rate, Zishen Yutai Pills, Kuntai Capsules, Motherwort Granules, Jinfeng Pills, and Sophora Gel all exceeded 10%.
Among them, Zishen Yutai Pills had the fastest growth rate
.
2021E China's urban physical pharmacies TOP20 gynecological Chinese patent medicine brands Source: Minet.
com China's urban physical pharmacy terminal competition pattern of the TOP20 brands, Shanxi Guangyuyuan Guoyao's Dingkundan, Sichuan Enwei Pharmaceutical's Jieeryin lotion, Zhongjingwanxi Pharmaceutical's Xiaoyao Pill ranks in the top three
.
In terms of the number of brands, Zhuzhou Qianjin Pharmaceutical has the most, with 4
.
Among the top 10 products, Xiaoyao Pill has the most intense competition, including Zhongjing Wanxi Pharmaceutical, Jiuzhitang, Lanzhou Foci Pharmaceutical, Taiji Group Chongqing No.
2 Traditional Chinese Medicine Factory and more than 160 companies have production approvals
.
According to data from Minet.
com, sales of Xiaoyao Pills in urban physical pharmacies in China have risen steadily in recent years, and are expected to increase by more than 10% year-on-year in 2021, ranking second in the TOP20 gynecological Chinese patent medicine products
.
Among them, Zhongjing Wanxi Pharmaceutical has the largest market share, exceeding 60%, followed by Jiuzhitang
.
Among the brand TOP20, Zhuzhou Qianjin Pharmaceutical has 4 products on the list
.
Among them, Fuke Qianjin Tablets and Fuke Qianjin Capsules are exclusive products, and Jiawei Xiaoyao Pills maintain rapid growth
.
According to data from Minet.
com, the terminal sales of Zhuzhou Qianjin Pharmaceutical's Jiawei Xiaoyao Pills will increase by more than 60% in physical pharmacies in Chinese cities in 2020, and it is expected to hit a new high in 2021.

.
Qianjin Pharmaceutical stated that the company has initially established a business structure for the entire pharmaceutical industry chain including pharmaceutical manufacturing, pharmaceutical distribution and traditional Chinese medicine cultivation
.
At the same time, the company adheres to the development strategy of "jumping out of gynecology, making women's health series; jumping out of the industry, making series of derivatives of traditional Chinese medicine", with gynecological traditional Chinese medicine as the core, and gradually extending to the field of women's health industry
.
The company's performance report shows that in 2021, revenue is 3.
665 billion yuan, a year-on-year increase of 1.
06%; net profit is 302 million yuan, a year-on-year increase of 1.
62%
.
China Resources, Tasly.
.
.
New medicines are hot in the past 5 years.
Gynecological Chinese patent medicines reported for production/clinical review in the past 5 years Source: Minet.
com MED2.
0 China Drug Evaluation Database In the past 5 years, the only Chinese patent medicines for gynecology are Kunxinning Granules from Tasly Pharmaceutical Group , Jinrong Xiaopi Granules from Guangzhou Kangyuan Pharmaceutical Co.
, Ltd.
and Gengshu Granules from Tonghua Wantong Pharmaceutical Co.
, Ltd.
were approved for listing
.
In January this year, Taohong Siwu Granules of Hefei China Resources Shenlu Pharmaceutical Co.
, Ltd.
, a subsidiary of China Resources Sanjiu, submitted a marketing application under the new drug category 3.
1.
The product is a gynecological menstrual adjustment drug
.
In addition, 8 products have been approved for clinical use, including Tasly Pharmaceutical Group's Qiling Wenshen Xiaonang Granules, Jiangxi Baishen Changnuo Pharmaceutical's Jingyankang Gel, Wuhan Hengxinyuan Pharmaceutical's Xianghudangxiongxingtiao Capsules, etc.
, Baiyunshan Zhongyi Pharmaceutical's Zishen Yutai Pills increases the indication of "decreased ovarian reserve"
.
Conclusion In recent years, the launch of new traditional Chinese medicines has been accelerating.
In 2021, a total of 12 new traditional Chinese medicines have been approved for marketing, the number reaching a new high in the past five years, involving women's menopause drugs, diabetes drugs, orthopaedic painkillers, cold drugs and other therapeutic fields
.
This year's government work report proposes to support the revitalization and development of traditional Chinese medicine and promote the comprehensive reform of traditional Chinese medicine
.
Under the background of national top-level policy support, aging population, and internationalization, the traditional Chinese medicine industry has huge room for growth, and various fields will usher in a golden period of development.

.
Source: Minet database, company announcement Note: Minet China's urban physical pharmacy terminal competition pattern database is an enlarged version of physical pharmacies covering 297 cities and above across the country (excluding county and rural physical pharmacies), which continuously monitors all categories.
A database of urban brick-and-mortar pharmacies
.
The above sales are calculated based on the average retail price of the product in the terminal
.
The statistics are as of March 7th, if there are any omissions, please correct me!